Acute and reversible parkinsonism due to organophosphate pesticide intoxication: Five cases

Neurology

Volumn 52, Issue 7, 1999, Pages 1467-1471

  Bhatt, Mohit H ^a   Elias, Mikhail A ^a   Mankodi, Ami K ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LEVODOPA; ORGANOPHOSPHATE INSECTICIDE;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTAMINATION; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INSECT CONTROL; INTOXICATION; PARKINSONISM; PESTICIDE SPRAYING; PRIORITY JOURNAL; SUICIDE ATTEMPT;

EID: 0033594348     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.7.1467     Document Type: Article

References (45)

1. Seidler A. Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996;46:1275-1284.
2. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997;48:1583-1588.
3. Chase TN. A gene for Parkinson's disease. Arch Neurol 1997; 54:1156-1157.
4. Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985;35:949-956.
5. Sechi GP, Agnetti V, Piredda M, et al. Acute and persistent parkinsonism after use of diquat. Neurology 1992;42:261-263.
6. Sanchez-Ramos JR, Hefti F, Weiner WJ. Paraquat and Parkinson's disease. Neurology 1987;37:728. Letter.
7. Bocchetta A, Corsini GU. Parkinson's disease and pesticides. Lancet 1986;2:1163.
8. Karsh FG, Lasagna L. Adverse drug reactions: a critical review. JAMA 1975;234:1236-1241.
9. De Bleecker JL, De Reuck JL, Willems JL. Neurological aspects of organophosphate poisoning. Clin Neurol Neurosurg 1992;94:93-103.
10. Joubert J, Joubert PH, van der Spuy M, van Graan E. Acute organophosphate poisoning presenting with choreo-athetosis. J Toxicol Clin Toxicol 1984;22:187-191.
11. Joubert J, Joubert PH. Chorea and psychiatric changes in organophosphate poisoning: a report of 2 further cases. South Afr Med J 1988;74:32-34.
12. Senanayake N, Sanmuganathan PS. Extrapyramidal manifestations complicating organophosphorus insecticide poisoning. Hum Exp Toxicol 1995;14:600-604.
13. Wright JM, Wall RA, Perry TL, Paty DW. Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis. N Engl J Med 1984;310:325. Letter.
14. Langston JW, Ballard PA. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. N Engl J Med 1983;309:310. Letter.
15. Barbeau A, Roy M, Langston JW. Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Lancet 1985;1:747.
16. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483.
17. Ferraz HB, Bertolucci PH, Pereira JS, Lima JG, Andrade LA. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988;38:550-553.
18. Meco G, Bonifati V, Vanacore N, Fabrizio E. Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scand J Work Environ Health 1994;20:301-305.
19. Peters HA, Levine RL, Matthews CG, Chapman LJ. Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure. Arch Neurol 1988;45: 537-540.
20. Melamed E, Lavy S. Parkinsonism associated with chronic inhalation of carbon tetrachloride. Lancet 1977;1:1015.
21. Pezzoli G, Barbieri S, Ferrante C, et al. Parkinsonism due to n-hexane exposure. Lancet 1989;2:874.
22. Uitti RJ, Snow BJ, Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994;35:616-619.
23. McLean DK, Jacobs H, Mielke BW. Methanol poisoning: a clinical and pathologic study. Ann Neurol 1980;8:161-167.
24. Guggenheim MA, Couch JR, Weinberg W. Motor dysfunction as a permanent complication of methanol ingestion. Arch Neurol 1971;24:550-554.
25. McCrank E. Parkinsonism secondary to petroleum ingestion. Neurology 1995;45:2112. Letter.
26. Tetrud JW, Langston JW, Irwin I, Snow B. Parkinsonism caused by petroleum waste ingestion. Neurology 1994;44: 1051-1054.
27. Montastruc JL, Llau ME, Rascol O, Senard JM. Drug-induced parkinsonism: a review. Fundam Clin Pharmacol 1994;8:293-306.
28. Krueger MJ, Singer TP, Casida JE, Ramsay RR. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone. Biochem Biophys Res Commun 1990;169:123-128.
29. Burn DJ, Brooks DJ. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study. Neurology 1993;43:552-556.
30. Vaccari A, Saba P. The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins. Eur J Pharmacol 1995;292:309-314.
31. Holmuhamedov EL, Kholmoukhamedova GL, Baimuradov TB. Non-cholinergic toxicity of organophosphates in mammals: interaction of ethaphos with mitochondrial functions. J Appl Toxicol 1996;16:475-481.
32. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671.
33. Jeyaratnam J. Pesticide poisoning: a major global health problem. World Health Stat Q 1990;43:139-144.
34. Tanner CM, Hubble JP, Chan P. Epidemiology and genetics of Parkinson's disease. In: Watts RL, Koller WC, eds. Movement disorders. Neurologic principles and practices. New York: McGraw-Hill, 1997:137-152.
35. Tanner CM, Chen B, Wang W, et al. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 1989;39:660-664.
36. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 1988;45:1321-1323.
37. Wooten GF, Currie LJ, Bennett JP, et al. Maternal inheritance in Parkinson's disease. Ann Neurol 1997;41:265-268.
38. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-1199.
39. 18F-dopa and positron emission tomography. Neurology 1992;42:1894-1900.
40. Bandmann O, Vaughan J, Holmans P, et al. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997;350:1136-1139.
41. Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 1985;2:1213-1216.
42. Wilhelmsen K, Mirel D, Marder K, et al. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13? Ann Neurol 1997;41:813-817.
43. World Health Organization. Organophosphorus insecticides: a general introduction. Environmental Health Criteria 63. Geneva: World Health Organization, 1986.
44. Furlong CE, Richter RJ, Seidel SL, Motulsky AG. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 1988;43:230-238.
45. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998;352:1344-1346.